Yonsei Med J.  2007 Dec;48(6):981-987. 10.3349/ymj.2007.48.6.981.

Surgical Outcome of Synchronous Second Primary Cancer in Patients with Gastric Cancer

• Ha TK
• An JY
• Youn HG
• Noh JH
• Sohn TS
• Kim S

• KMID: 1786213
• DOI: http://doi.org/10.3349/ymj.2007.48.6.981

Abstract

PURPOSE: In order to improve the likelihood of curative and safe gastric surgery, this study investigated the clinical features and surgical outcomes of gastric cancer with a synchronous cancer. PATIENTS AND METHODS: The clinicopathological data of 10,090 gastric cancer patients at Samsung Medical Center from September 1994 to December 2006 were retrospectively analyzed. Of them, 90 patients with gastric cancer and a synchronous second primary cancer underwent simultaneous surgery for gastric cancer and second primary cancer. The clinicopathological characteristics of the patients, surgical outcome, and prognosis were examined. RESULTS: The most common synchronous second primary cancer was colorectal cancer (37 patients), followed by hepatocellular carcinoma (13 patients), renal cell carcinoma (11 patients), and pancreatic carcinoma (5 patients). The incidence of a second primary cancer in the gastric cancer patients was higher than the incidence in the general population. Stage I gastric cancer patients had more synchronous cancers than stage II patients (59 vs. 31). Postoperative complications were encountered in 7 patients. Four patients underwent reoperation. Two patients died from hepatic failure and leakage of esophagojejunal anastomosis. The 5-year survival rate of stage I and II gastric cancer was 61% and 39%, respectively. CONCLUSION: Since gastric cancer patients with a synchronous second primary cancer are not rare, the possibility of synchronous cancers in gastric cancer patients should be considered. The prognosis of early stage gastric cancer patients with a synchronous second primary cancer was influenced more by the presence of the second primary cancer than by the gastric cancer itself.

Keyword

Second primary cancer; gastric cancer

MeSH Terms

Adult
Aged
Carcinoma, Hepatocellular/pathology/surgery
Carcinoma, Renal Cell/pathology/surgery
Colorectal Neoplasms/pathology/surgery
Female
Humans
Male
Middle Aged
Neoplasm Staging
Neoplasms, Second Primary/pathology/*surgery
Pancreatic Neoplasms/pathology/surgery
Prognosis
Retrospective Studies
Stomach Neoplasms/pathology/*surgery
Survival Analysis
Treatment Outcome

Figure

• 

  Fig. 1 Incidence of second primary cancer and incidence. *Other: duodenum, breast, prostate, ureter, appendix, melanoma, mucoepidermoid tumor, cervix. †Data for cancer incidence was based on annual report of the Korea Central Cancer Registry 2001.

Reference

1. Bae JM, Jung KW, Won YJ. Estimation of cancer deaths in Korea for the upcoming years. J Korean Med Sci. 2002. 17:611–615.

2. Kim YS, Park HA, Kim BS, Yook JH, Lee MS. Efficacy of screening for gastric cancer in a Korean adult population: a case-control study. J Korean Med Sci. 2000. 15:510–515.

3. Sastre J, Garcia-Saenz JA, Diaz-Rubio E. Chemotherapy for gastric cancer. World J Gastroenterol. 2006. 12:204–213.

4. Yoshida S, Kozu T, Gotoda T, Saito D. Detection and treatment of early cancer in high-risk populations. Best Pract Res Clin Gastroenterol. 2006. 20:745–765.

5. Zhang XF, Huang CM, Lu HS, Wu XY, Wang C, Guang GX, et al. Surgical treatment and prognosis of gastric cancer in 2,613 patients. World J Gastroenterol. 2004. 10:3405–3408.

6. Lee JH, Bae JS, Ryu KW, Lee JS, Park SR, Kim CG, et al. Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol. 2006. 12:2588–2592.

7. Ikeda Y, Saku M, Kawanaka H, Nonaka M, Yoshida K. Features of second primary cancer in patients with gastric cancer. Oncology. 2003. 65:113–117.

8. Yoshino K, Asanuma F, Hanatani Y, Otani Y, Kumai K, Ishibiki K. Multiple primary cancers in the stomach and another organ: frequency and the effects on prognosis. Jpn J Clin Oncol. 1985. 15:Suppl 1. 183–190.

9. Cheng HY, Chu CH, Chang WH, Hsu TC, Lin SC, Liu CC, et al. Clinical analysis of multiple primary malignancies in the digestive system: a hospital-based study. World J Gastroenterol. 2005. 11:4215–4219.

10. Furukawa H, Hiratsuka M, Iwanaga T, Imaoka S, Kabuto T, Ishikawa O, et al. Treatments for second malignancies after gastrectomy for stomach cancer. Hepatogastroenterology. 1996. 43:194–198.

11. Ikeguchi M, Ohfuji S, Oka A, Tsujitani S, Maeda M, Kaibara N. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer. Hepatogastroenterology. 1995. 42:672–676.

12. Nio Y, Hirahara N, Minari Y, Sasaki S, Takamura M, Sato Y, et al. Second malignancies after a gastrectomy for gastric cancers: the effects of adjuvant therapies. Anticancer Res. 1999. 19:3591–3599.

13. Lee HJ, Yang HK, Ahn YO. Gastric cancer in Korea. Gastric Cancer. 2002. 5:177–182.

14. Kim JP, Hur YS, Yang HK. Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1,136 early gastric cancers. Ann Surg Oncol. 1995. 2:308–313.

15. Gylling A, Abdel-Rahman WM, Juhola M, Nuorva K, Hautala E, Jarvinen HJ, et al. Is gastric cancer part of the tumor spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. Gut. 2007. 56:926–933.

16. Keller G, Grimm V, Vogelsang H, Bischoff P, Mueller J, Siewert JR, et al. Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer. Int J Cancer. 1996. 68:571–576.

17. Kim JC, Kim HC, Roh SA, Koo KH, Lee DH, Yu CS, et al. hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer. Cancer Detect Prev. 2001. 25:503–510.

18. Koide N, Hanazaki K, Fujimori Y, Igarashi J, Kajikawa S, Adachi W, et al. Synchronous gastric cancer associated with hepatocellular carcinoma: a study of 10 patients. Hepatogastroenterology. 1999. 46:3008–3014.

19. Shimada M, Takenaka K, Fujiwara Y, Gion T, Shirabe K, Nishizaki T, et al. Characteristics of hepatocellular carcinoma associated with extrahepatic primary malignancies in southern Japan. Am J Gastroenterol. 1996. 91:754–758.

20. Shuto T, Hirohashi K, Kubo S, Tanaka H, Tsukamoto T, Yamamoto T, et al. Changes and results of surgical strategies for hepatocellular carcinoma: results of a 15-year study on 452 consecutive patients. Surg Today. 1998. 28:1124–1129.

21. Isozaki H, Okajima K, Ichinona T, Fujii K, Nomura E, Izumi N. Surgery for gastric cancer in patients with cirrhosis. Surg Today. 1997. 27:17–21.

22. Murakami S, Yashuda S, Nakamura T, Mishima Y, Iida H, Okano H, et al. A case of renal cell carcinoma with metastasis to the thyroid gland and concomitant early gastric cancer. Surg Today. 1993. 23:153–158.

23. Uemura T, Kurita A, Nishimura R, Ishizaki M, Takashima S. Solitary pancreatic metastasis from renal cell carcinoma concomitant with early gastric cancer 17 years after nephrectomy: report of a case. Surg Today. 2003. 33:395–398.

24. Beisland C, Talleraas O, Bakke A, Norstein J. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU Int. 2006. 97:698–702.

25. Urano Y, Itoyama S, Fukushima T, Kitamura S, Mori H, Baba K, et al. Multiple primary cancers in autopsy cases of Tokyo University Hospital (1883-1982) and in Japan Autopsy Annuals (1974-1982). Jpn J Clin Oncol. 1985. 15:Suppl 1. 271–279.